Damjana Bogatic

Damjana Bogatic

Adelaide Medical School

Faculty of Health and Medical Sciences

  • Appointments
    Date Position Institution name
    2024 - ongoing Inflammatory Bowel Disease Fellow Queen Elizabeth Hospital
    2024 - ongoing Higher Degree by Research Candidate University of Adelaide

  • Education
    Date Institution name Country Title
    2020 University of Newcastle Australia Australia Master of Public Health with Distinction
    2018 Flinders University Australia Doctor of Medicine
    2013 Flinders University Australia Bachelor of Medical Science

  • Journals
    Year Citation
    2024 Bogatic, D., & Bryant, R. V. (2024). Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease—hope on the horizon. Alimentary Pharmacology and Therapeutics, 60(4), 535-536.
    DOI
    2024 Bogatic, D., & Bryant, R. V. (2024). Letter: Gut microbiota—An overlooked therapeutic target in the prevention of post-operative recurrence of Crohn's disease. Alimentary Pharmacology and Therapeutics, 60(10), 1501-1502.
    DOI
    2023 Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2023). Cover Image. Alimentary Pharmacology & Therapeutics, 57(1).
    DOI
    2022 Loo, K. F., Woodman, R. J., Bogatic, D., Chandran, V., Muller, K., Chinnaratha, M. A., . . . Wigg, A. (2022). High rates of treatment stage migration for early hepatocellular carcinoma and association with adverse outcomes: An Australian multicenter study. JGH Open, 6(9), 599-606.
    DOI Scopus2 Europe PMC3
    2022 Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2022). Microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics, 57(1), 23-36.
    DOI Scopus6 Europe PMC4
Connect With Me
External Profiles